Better Therapeutics’ $187 Million Merger Agreement with Mountain Crest Acquisition Corp II

Goodwin Procter LLP advised Better Therapeutics, Inc. on the deal.Better Therapeutics, Inc. announced its definitive merger agreement with Mountain Crest Acquisition Corp II (Nasdaq: MCAD;), a publicly…

This content is for members only.
Login to Read More Join Now
Martina Bellini

Author: Martina Bellini

This content is for members only.
Login to Read More Join Now